Cargando…
Design, Synthesis, and Anti-Breast Cancer Potential of Imidazole–Pyridine Hybrid Molecules In Vitro and Ehrlich Ascites Carcinoma Growth Inhibitory Activity Assessment In Vivo
[Image: see text] Breast cancer remains a challenging medical issue and is a high priority for biomedical research despite significant advancements in cancer research and therapy. The current study aims to determine the anticancer activity of a group of imidazole–pyridine-based scaffolds against a v...
Autores principales: | Aruchamy, Baladhandapani, Kuruburu, Mahadevaswamy G., Bovilla, Venugopal R., Madhunapantula, SubbaRao V., Drago, Carmelo, Benny, Sonu, Presanna, Aneesh Thankappan, Ramani, Prasanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620790/ https://www.ncbi.nlm.nih.gov/pubmed/37929115 http://dx.doi.org/10.1021/acsomega.3c04384 |
Ejemplares similares
-
Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
por: Bovilla, Venugopal R., et al.
Publicado: (2021) -
Bioactive profiling and evaluation of anti-proliferative and anti-cancerous properties of Shivagutika, an Indian polyherbal formulation synchronizing in vitro and in silico approaches
por: V. H., Pushpa, et al.
Publicado: (2023) -
Vitamin D3 Inhibits the Viability of Breast Cancer Cells In Vitro and Ehrlich Ascites Carcinomas in Mice by Promoting Apoptosis and Cell Cycle Arrest and by Impeding Tumor Angiogenesis
por: Veeresh, Prashanth Kumar M., et al.
Publicado: (2023) -
The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
por: Beeraka, Narasimha M., et al.
Publicado: (2021) -
Providing Diabetes Education through Phone Calls Assisted in the Better Control of Hyperglycemia and Improved the Knowledge of Patients on Diabetes Management
por: Kundury, Kanakavalli K., et al.
Publicado: (2023)